These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12847698)

  • 1. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman.
    García-Pavía P; Torres RJ; Rivero M; Ahmed M; García-Puig J; Becker MA
    Arthritis Rheum; 2003 Jul; 48(7):2036-41. PubMed ID: 12847698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase.
    Ahmed M; Taylor W; Smith PR; Becker MA
    J Biol Chem; 1999 Mar; 274(11):7482-8. PubMed ID: 10066814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased activity of PRPP synthetase].
    Iizasa T
    Nihon Rinsho; 2008 Apr; 66(4):694-8. PubMed ID: 18409517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene.
    Roessler BJ; Nosal JM; Smith PR; Heidler SA; Palella TD; Switzer RL; Becker MA
    J Biol Chem; 1993 Dec; 268(35):26476-81. PubMed ID: 8253776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.
    Yang BY; Yu HX; Min J; Song XX
    Clin Rheumatol; 2020 Mar; 39(3):949-956. PubMed ID: 31773495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism of purine nucleotides and the production of uric acid].
    Yamaoka T; Itakura M
    Nihon Rinsho; 1996 Dec; 54(12):3188-94. PubMed ID: 8976090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.
    Becker MA; Smith PR; Taylor W; Mustafi R; Switzer RL
    J Clin Invest; 1995 Nov; 96(5):2133-41. PubMed ID: 7593598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of distinct PRS1 mutations in two patients with X-linked phosphoribosylpyrophosphate synthetase superactivity.
    Roessler BJ; Golovoy N; Palella TD; Heidler S; Becker MA
    Adv Exp Med Biol; 1991; 309B():125-8. PubMed ID: 1664177
    [No Abstract]   [Full Text] [Related]  

  • 14. N114S mutation causes loss of ATP-induced aggregation of human phosphoribosylpyrophosphate synthetase 1.
    Liu H; Peng X; Zhao F; Zhang G; Tao Y; Luo Z; Li Y; Teng M; Li X; Wei S
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1120-5. PubMed ID: 19161981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
    Losman MJ; Hecker S; Woo S; Becker MA
    J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the phosphoribosylpyrophosphate synthetase gene from Candida albicans.
    Payne T; Calderone R
    J Med Vet Mycol; 1997; 35(5):305-12. PubMed ID: 9402522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type and feedback-resistant phosphoribosyl pyrophosphate synthetases from Bacillus amyloliquefaciens: purification, characterization, and application to increase purine nucleoside production.
    Zakataeva NP; Romanenkov DV; Skripnikova VS; Vitushkina MV; Livshits VA; Kivero AD; Novikova AE
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):2023-33. PubMed ID: 22083279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small disturbance, but a serious disease: the possible mechanism of D52H-mutant of human PRS1 that causes gout.
    Chen P; Li J; Ma J; Teng M; Li X
    IUBMB Life; 2013 Jun; 65(6):518-25. PubMed ID: 23509005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    J Clin Invest; 1980 Jan; 65(1):109-20. PubMed ID: 6243137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors associated with gout and hyperuricemia.
    Bleyer AJ; Hart TC
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):124-30. PubMed ID: 16580613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.